Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation

Head and Neck

Volumn 31, Issue 5, 2009, Pages 593-603

  Van Der Putten, Lisa ^a,b   Van Den Broek, Guido B ^a,c   De Bree, Remco ^b   Van Den Brekel, Michiel W M ^a,c   Balm, Alfons J M ^a,c   Hoebers, Frank J P ^a   Doornaert, Patricia ^b   Leemans, C René ^b   Rasch, Coen R N ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Advanced stage; Chemoradiation; Head and neck cancer; Neck dissection; Salvage

Indexed keywords

CISPLATIN; FLUOROURACIL; SODIUM THIOSULFATE;

ADVANCED CANCER; ARTICLE; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THERAPY EFFECT; TREATMENT OUTCOME;

BIOPSY, FINE-NEEDLE; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 66349096726     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20987     Document Type: Article

References (49)

1. Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000;355:949-955.
2. Forastiere AA. Larynx preservation trials: a critical appraisal. Semin Radiat Oncol 1998;8:254-261. (Pubitemid 28460810)
3. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25:791-798.
4. Narayan K, Crane CH, Kleid S, Hughes PJ, Peters LJ. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck 1999;21:606-613.
5. Weisman RA, Robbins KT. Management of the neck in patients with head and neck cancer treated by concurrent chemotherapy and radiation. Otolaryngol Clin North Am 1998;31:773-784. (Pubitemid 28489087)
6. Robbins KT, Wong FS, Kumar P, et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125:670-675. (Pubitemid 29269843)
7. Corry J, Smith JG, Peters LJ. The concept of a planned neck dissection is obsolete. Cancer J 2001;7:472-474. (Pubitemid 41710839)
8. Pellitteri PK, Ferlito A, Rinaldo A, et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck 2006;28:166-175.
9. Grabenbauer GG, Rodel C, Ernst-Stecken A, et al. Neck dissection following radiochemotherapy of advanced head and neck cancer-for selected cases only? Radiother Oncol 2003;66:57-63.
10. Lavertu P, Bonafede JP, Adelstein DJ, et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1998;124:401-406. (Pubitemid 28178310)
11. Davidson BJ, Newkirk KA, Harter KW, Picken CA, Cullen KJ, Sessions RB. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 1999;125:401-405. (Pubitemid 29169766)
12. Sassler AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy. Analysis of wound complications. Arch Otolaryngol Head Neck Surg 1995;121:162-165.
13. Sanguineti G, Corvo R, Benasso M, et al. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck 1999;21:223-228. (Pubitemid 29144582)
14. Wolf GT, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 1992;102:934-939.
15. Ojiri H, Mendenhall WM, Stringer SP, Johnson PL, Mancuso AA. Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2002;52:420-428. (Pubitemid 34173003)
16. Ojiri H, Mancuso AA, Mendenhall WM, Stringer SP. Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy. AJNR Am J Neuroradiol 2002;23:1627-1631. (Pubitemid 35304091)
17. Brkovich VS, Miller FR, Karnad AB, Hussey DH, McGuff HS, Otto RA. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 2006;116:855-858. (Pubitemid 44317978)
18. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000;126:950-956. (Pubitemid 30658293)
19. Stenson KM, Huo D, Blair E, et al. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope 2006;116:33-36. (Pubitemid 44383957)
20. Robbins KT, Doweck I, Samant S, Vieira F. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg 2005;131:965-969. (Pubitemid 41696390)
21. de Jong RJB, Rongen RJ, Verwoerd CD, et al. Ultrasound-guided fine-needle aspiration biopsy of neck nodes. Arch Otolaryngol Head Neck Surg 1991;117:402-404.
22. Hodder SC, Evans RM, Patton DW, Silvester KC. Ultrasound and fine needle aspiration cytology in the staging of neck lymph nodes in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 2000;38:430-436.
23. Knappe M, Louw M, Gregor RT. Ultrasonography-guided fine-needle aspiration for the assessment of cervical metastases. Arch Otolaryngol Head Neck Surg 2000;126:1091-1096.
24. Takes RP, Knegt P, Manni JJ, et al. Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB. Radiology 1996;198:819-823. (Pubitemid 26066304)
25. van den Brekel MW, Reitsma LC, Quak JJ, et al. Sonographically guided aspiration cytology of neck nodes for selection of treatment and follow-up in patients with N0 head and neck cancer. AJNR Am J Neuroradiol 1999;20:1727-1731. (Pubitemid 29498630)
26. Balm AJ, Rasch CR, Schornagel JH, et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 2004;26:485-493. (Pubitemid 38702635)
27. Robbins KT, Kumar P, Wong FS, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000;22:687-693.
28. Robbins KT, Kumar P, Regine WF, et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 1997;38:263-271. (Pubitemid 27318641)
29. Hoebers FJ, Heemsbergen W, Balm AJ, van Zanten M, Schornagel JH, Rasch CR. Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma. Radiother Oncol 2007;85:42-47. (Pubitemid 47570059)
30. Lefebvre J, Horiot J, Rolland F, et al. Phase III study on larynx preservation comparing induction chemotherapy and radiotherapy versus alternating chemoradiotherapy in resectable hypopharynx and larynx cancers. EORTC protocol 24954-122950 J Clin Oncol 2007;25 (Suppl 18):A-LBA6016-303s (abstract).
31. Gupta T, Agarwal JP. Planned neck dissection following chemo-radiotherapy in advanced HNSCC. Int Semin Surg Oncol 2004;1:6. (Pubitemid 40617800)
32. Goguen LA, Posner MR, Tishler RB, et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2006;132:526-531. (Pubitemid 43742571)
33. Mendenhall WM, Villaret DB, Amdur RJ, Hinerman RW, Mancuso AA. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2002;24:1012-1018. (Pubitemid 35217111)
34. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447-455. (Pubitemid 38569204)
35. Richey LM, Shores CG, George J, et al. The effectiveness of salvage surgery after the failure of primary concomitant chemoradiation in head and neck cancer. Otolaryngol Head Neck Surg 2007;136:98-103. (Pubitemid 46037889)
36. van den Brekel MWM, Castelijns JA. Radiologic evaluation of neck metastases: the otolaryngologist's perspective. Semin US-CT-MRI 1999;20:162-174. (Pubitemid 29275449)
37. Righi PD, Kopecky KK, Caldemeyer KS, Ball VA, Weisberger EC, Radpour S. Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck 1997;19:604-610. (Pubitemid 27407315)
38. van den Brekel MW, Castelijns JA, Reitsma LC, Leemans CR, van der Waal I, Snow GB. Outcome of observing the N0 neck using ultrasonographic-guided cytology for follow-up. Arch Otolaryngol Head Neck Surg 1999;125:153-156. (Pubitemid 29085263)
39. Yuasa K, Kawazu T, Kunitake N, et al. Sonography for the detection of cervical lymph node metastases among patients with tongue cancer: criteria for early detection and assessment of follow-up examination intervals. AJNR Am J Neuroradiol 2000;21:1127-1132. (Pubitemid 30390556)
40. Budach VGDS, Haake K, Stuschke M, et al. Accelerated chemoradiation to 70.6 Gy is more effective than accelerated radiation to 77.6 Gy alone - two year results of a German multicenter randomized trial. Int J Radiat Oncol Biol Phys 2000;48 (Suppl 1):150-151 (abstract).
41. Calais G, Alfonsi M, Bardet E, et al. Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy [in French]. Bull Cancer 2000;87 Spec No:48-53.
42. Velazquez RA, McGuff HS, Sycamore D, Miller FR. The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2004;130:74-77. (Pubitemid 38095433)
43. van den Brekel MW, Stel HV, van derValk P, van der Waal I, Meyer CJ, Snow GB. Micrometastases from squamous cell carcinoma in neck dissection specimens. Eur Arch Otorhinolaryngol 1992;249:349-353.
44. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2005;27:175-181. (Pubitemid 40315765)
45. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 2004;58:694-697.
46. McCollum AD, Burrell SC, Haddad RI, et al. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 2004;26:890-896. (Pubitemid 39299309)
47. Yao M, Smith RB, Graham MM, et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 2005;63:991-999. (Pubitemid 41505274)
48. Nayak JV, Walvekar RR, Andrade RS, et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 2007;117:2129-2134.
49. Robbins KT, Shannon K, Vieira F. Superselective neck dissection after chemoradiation: feasibility based on clinical and pathologic comparisons. Arch Otolaryngol Head Neck Surg 2007;133:486-489. (Pubitemid 46799786)